Welcome to LookChem.com Sign In|Join Free

CAS

  • or

481681-02-1

Post Buying Request

481681-02-1 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

481681-02-1 Usage

Uses

suzuki reaction

Check Digit Verification of cas no

The CAS Registry Mumber 481681-02-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 4,8,1,6,8 and 1 respectively; the second part has 2 digits, 0 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 481681-02:
(8*4)+(7*8)+(6*1)+(5*6)+(4*8)+(3*1)+(2*0)+(1*2)=161
161 % 10 = 1
So 481681-02-1 is a valid CAS Registry Number.
InChI:InChI=1/C7H8BFO3/c9-7-2-1-6(8(11)12)3-5(7)4-10/h1-3,10-12H,4H2

481681-02-1 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • TCI America

  • (F1090)  4-Fluoro-3-(hydroxymethyl)phenylboronic Acid (contains varying amounts of Anhydride)  

  • 481681-02-1

  • 200mg

  • 790.00CNY

  • Detail
  • TCI America

  • (F1090)  4-Fluoro-3-(hydroxymethyl)phenylboronic Acid (contains varying amounts of Anhydride)  

  • 481681-02-1

  • 1g

  • 2,990.00CNY

  • Detail
  • Alfa Aesar

  • (H52487)  4-Fluoro-3-(hydroxymethyl)benzeneboronic acid, 98%   

  • 481681-02-1

  • 250mg

  • 1390.0CNY

  • Detail
  • Alfa Aesar

  • (H52487)  4-Fluoro-3-(hydroxymethyl)benzeneboronic acid, 98%   

  • 481681-02-1

  • 1g

  • 4445.0CNY

  • Detail

481681-02-1Relevant articles and documents

PYRIMIDINYL GROUP-CONTAINING TRICYCLIC COMPOUND SERVING AS C-MET INHIBITOR

-

Paragraph 0471-0473, (2021/12/18)

Disclosed are a pyrimidinyl group-containing tricyclic compound and applications thereof in preparing a cancer-treating medicament. Specifically disclosed are a compound as represented by formula (I), a pharmaceutically acceptable salt of same, or an isomer thereof.

PHOSPHONATE CONJUGATES AND USES THEREOF

-

Paragraph 00159; 00168-00169, (2020/07/31)

Phosphonate conjugates, preferably, bisphosphonate conjugates; methods of inhibiting Ron receptor tyrosine kinase and methods of treatment of bone destruction due to cancer or other conditions utilizing the provided phosphonate conjugates.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 481681-02-1